BINGHAMTON, New York, Sept. 3 (TNSjou) -- Binghamton University issued the following news:

* * *

New blood biomarkers reveal how common muscular dystrophy treatment may impair overall growth

Study shows a drug created by Binghamton researcher used to treat Duchenne Muscular dystrophy avoids suppressing bone- and cartilage-related proteins, biomarker changes recover after boys' transition from corticosteroid

By Ethan Knox '20